Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 51407-561

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 51407-561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-557-01.jpg (51407 557 01)

51407-557-01.jpg (51407 557 01)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules, 5 mg strength. The label highlights the drug as a Schedule II controlled substance and includes detailed ingredient amounts, storage instructions, and dispensing guidelines. The labeler is GSMS (Golden State Medical Supply, Inc.), with distribution by Lannett Company, Inc., and the package contains 100 capsules.*
FDA Label Image

51407-558-01.jpg (51407 558 01)

51407-558-01.jpg (51407 558 01)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 10 mg strength. The label states the active ingredients each capsule contains (2.5 mg each of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate). It includes storage instructions, manufacturer (GSMS, Incorporated), distributor (Lannett Company, Inc.), and a note to pharmacists to dispense with a medication guide. Package quantity is 100 capsules.*
FDA Label Image

51407-559-01.jpg (51407 559 01)

51407-559-01.jpg (51407 559 01)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules, 15 mg strength. The label includes the NDC 51407-559-01, states the capsule contains 3.75 mg each of the four amphetamine salts with a total amphetamine base equivalence of 9.4 mg, and specifies packaging of 100 capsules. It is marketed by GSMS, Incorporated and distributed by Lannett Company, Inc.*
FDA Label Image

51407-560-01.jpg (51407 560 01)

51407-560-01.jpg (51407 560 01)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules, 20 mg, by Golden State Medical Supply, Inc. The label lists active ingredients with 5 mg each and total amphetamine base equivalence of 12.5 mg. It includes storage instructions, packaging details for 100 capsules, a barcode, and references the medication guide at gsms.us.*
FDA Label Image

51407-561-01.jpg (51407 561 01)

51407-561-01.jpg (51407 561 01)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules. The label indicates a 25 mg strength with 100 capsules per container. It includes storage instructions, dosing information, and the labeler Golden State Medical Supply, Inc. The label also features barcodes and a medication guide URL.*
FDA Label Image

51407-562-01.jpg (51407 562 01)

51407-562-01.jpg (51407 562 01)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 30 mg strength. Includes active ingredient amounts per capsule, storage instructions, and emphasizes dispensing with medication guide. Pack contains 100 capsules. Marketed by GSMS, Inc. and distributed by Lannett Company, Inc. NDC 51407-562-01 shown with barcodes.*
FDA Label Image

Figure (Dextroamphetamine Saccharate Amphetamine Aspartate 1)

Figure (Dextroamphetamine Saccharate Amphetamine Aspartate 1)
A line graph showing mean plasma concentrations of dextroamphetamine and levoamphetamine (ng/mL) over 24 hours. It compares four formulations: 20 mg once daily extended-release capsules and 10 mg twice daily tablets of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. The x-axis represents time in hours, and the y-axis shows concentration levels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.